Private Market View

Ambagon Therapeutics

Drug Discovery · Eindhoven, Netherlands · Founded 2019 · Privately Held (backing)

Last price · $/share
Implied valuation
Total raised
$108.0M
Last round
Early Stage VC
Jan 2025
How much has Ambagon Therapeutics raised?
$108.0Macross 3 recorded rounds · Jul 2020Jan 2025

Most recently, Ambagon Therapeutics raised $5.0M in its Early Stage VC (Jan 2025).

Free account
See the evidence behind this price
  • ·Post-money valuations for all 3 rounds
  • ·The complete investor list — 13 names
  • ·Watchlist + deal alerts for Ambagon Therapeutics
Create free account
No card required

Round by round

3 rounds
Jan 2025Early Stage VC$5.0MSEC filing
4 investors participated
Jan 2022Early Stage VC (Series A)$85.0M
+ 1 more investors · free account
Jul 2020Early Stage VC$5.4MSEC filing
8 investors participated
For fundraisers
Raising for a company like Ambagon Therapeutics?

13 investors have backed Ambagon Therapeutics — start your target list with the firms already writing checks in drug discovery.

See all 13 investors →

Frequently asked

How much has Ambagon Therapeutics raised?
Ambagon Therapeutics has raised $108.0M in total across 3 recorded funding rounds.
When was Ambagon Therapeutics's last funding round?
Ambagon Therapeutics's most recent recorded round was Early Stage VC in Jan 2025, raising $5.0M.